June 07, 2018
Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers, starting with cervical cancer.
Nearly 80 million Americans – one out of every four people – are infected with human papillomavirus (HPV). And of those millions, more than 50,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.
The University of Kansas Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a Call to Action urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. These institutions collectively recognize insufficient vaccination as a significant public health threat and call upon the nations’ physicians, parents and young adults to take advantage of this rare opportunity to eliminate several different types of cancer in men and women.
Download the PDF.
“We have the opportunity to eliminate multiple HPV-related cancers beginning with cervical cancer. To accomplish this goal, we need to utilize our most important tool – HPV vaccination,” said Anna R. Giuliano, PhD, director of the Center for Infection Research in Cancer at Moffitt Cancer Center. “We are asking health care providers to stand with us and recommend the HPV vaccine. Parents can join with us by asking their doctors about vaccination.”
“HPV vaccination completion rates across the United States remain low,” said Roy Jensen, MD, director of KU Cancer Center. “In fact, Kansas and Missouri have some of the lowest HPV vaccination rates in the country and this is simply unacceptable. As the only NCI-designated cancer center in the region, it is our responsibility to help improve these statistics.”
Vaccination rates remain significantly lower than other recommended adolescent vaccines in the U.S. According to 2016 data from the Centers for Disease Control (CDC), less than 50 percent of girls and 38 percent of boys completed the recommended vaccine series. Research shows there are a number of barriers to overcome to improve vaccination rates, including a lack of strong recommendations from physicians and parents not understanding that this vaccine protects against several types of cancer in men and women. HPV causes multiple cancers including cervical, anal, oropharyngeal (middle throat) and other genital cancers.
Learn about KU Cancer Center’s HPV research efforts.
HPV experts from the nation’s top cancer centers, along with partners from the NCI, CDC, and the American Cancer Society, are meeting June 7-8, 2018 in Salt Lake City to discuss a path forward to eliminating cancers caused by HPV, including ways to reduce barriers to vaccination, as well as share education, training and intervention strategies to improve vaccination rates.
“The United States has an unprecedented opportunity to not just prevent cancers caused by HPV but to eliminate them. This means getting to a point in time when cancers such as cervical cancer are no longer diagnosed in our country,” said Giuliano.This is the third year that all NCI-designated cancer centers have come together to issue a national call to action. All 70 cancer centers unanimously share the goal of sending a powerful message to parents, adolescents and health care providers about the importance of HPV vaccination for the elimination of HPV-related cancers.